HealthTech & MedTech

Experian Health's survey shows 75% of healthcare providers struggle with rising claim denials.

8 sources · 5 insights

This week

Weekly verdict

Providers should prioritize AI investment to enhance claims management, as 84% of respondents recognize its potential.

What moved

  1. Experian Health's survey shows 75% of healthcare providers struggle with rising claim denials.
  2. CVS Health's 2028 split into two companies raises concerns about vertical integration and shareholder profit priorities.
  3. Mount Sinai receives $4M NIH grant to develop AI for predicting post-operative kidney injury.
  4. The FTC sent warning letters to 25 companies over deceptive healthcare marketing.
  5. The U.S. Department of Health and Human Services is easing health IT certification requirements.

See every call, including the wrong ones →

Intelligence ReportWeekly strategic synthesis

This week's stories highlight a critical theme of regulatory scrutiny and adaptation in HealthTech, particularly demonstrated by the FTC's warning letters to companies over deceptive marketing and the easing of health IT certification requirements by the U.S. Department of Health and Human Services. These developments signal an urgent need for companies to reassess their compliance strategies and prepare for a market where regulatory adherence is important to maintaining market credibility and operational viability.

For HealthTech and MedTech practitioners, the immediate concern is the heightened risk of regulatory penalties, which could materialize swiftly given the FTC's active stance. Companies should urgently audit their marketing strategies for compliance with FTC standards to avoid fines. Additionally, with the new health IT certification requirements, procurement contracts should be revised to include criteria for disclosure, validation, and bias testing by the end of 2026. This shift will likely impact budget allocations and operational priorities in the short term.

Non-obvious takeaway: A non-obvious second-order effect of these regulatory changes is the potential for increased collaboration between HealthTech companies and legal or compliance firms. As regulatory environments become more complex, the demand for specialized expertise in navigating these waters will likely rise. This could lead to a surge in partnerships or service agreements with firms that can offer compliance solutions, thereby creating a new niche market for legal-tech collaborations within the healthcare sector.

Full synthesis available to Pro subscribersUnlock Pro →
News 1

Experian Health's survey shows 75% of healthcare providers struggle with rising claim denials.

Context

Experian Health's 2026 State of Claims survey, with input from 204 healthcare professionals, reveals that 75% of respondents report an increase in claim denials, with 40% experiencing a denial rate of at least 10%. The survey identifies frequent changes in payer policies as a significant obstacle for providers.

What it means

Providers should prioritize AI investment to enhance claims management, as 84% of respondents recognize its potential. Improving front-end processes for accurate coverage and patient information is essential to reduce denial rates and safeguard revenue.

7

Track AI adoption in claims management by early 2027 to assess industry response and adaptation.

News 2

CVS Health's 2028 split into two companies raises concerns about vertical integration and shareholder profit priorities.

Context

CVS Health announced plans to restructure into two separate entities by 2028: CVS Health, including Aetna and other health services, and CVS Pharmacy, focusing on retail and community healthcare. This move is partly in response to regulatory pressures on vertical integration. The restructuring also aligns with broader legislative efforts to limit pharmacy benefit managers' control over pharmacies.

What it means

Healthcare professionals should prepare for potential changes in partnerships and service offerings as CVS Health redefines its business structure. Monitoring legislative developments around pharmacy benefit managers could provide insights into future regulatory impacts on similar healthcare conglomerates.

7

Watch for regulatory updates and CVS's strategic shifts that may affect service contracts and partnerships.

📊 Prediction, tracked for 28 days

We predict that CVS Health will announce the details of its restructuring plan within 28 days.

News 3

Mount Sinai receives $4M NIH grant to develop AI for predicting post-operative kidney injury.

Context

The Icahn School of Medicine at Mount Sinai has been awarded a $4 million grant from the NIH to create an AI model that predicts post-operative acute kidney injury (AKI) in surgical patients. This initiative will employ federated learning on data from over 320,000 patients across 15 hospitals. Approximately 12% of noncardiac surgery patients in the U.S. develop AKI annually, leading to increased hospital stays and costs.

What it means

HealthTech professionals should consider the implications of AI-driven predictive models in surgical care, which could optimize patient management and reduce hospital expenses. Engage with institutions pioneering similar technologies to explore collaborative opportunities.

6

Monitor Mount Sinai's progress in AI model development and potential early outcomes within the next two years.

News 4

The FTC sent warning letters to 25 companies over deceptive healthcare marketing.

Context

Last week, the FTC issued warning letters to 25 companies marketing Affordable Care Act Marketplace plans, citing potentially deceptive practices. This follows earlier warnings in October to 24 healthcare services companies about price transparency. The FTC's actions aim to protect consumers from misleading claims during open enrollment.

What it means

HealthTech companies must urgently audit their marketing strategies for compliance with FTC standards to avoid penalties. Expect increased regulatory oversight and potential enforcement actions that could affect market operations.

8

Monitor FTC announcements closely for further regulatory guidance impacting healthcare marketing by early 2027.

📊 Prediction, tracked for 28 days

We predict that Centene Corporation will announce a new partnership focused on compliance with FTC marketing regulations within 28 days.

News 5

The U.S. Department of Health and Human Services is easing health IT certification requirements.

Context

The HHS's final rule, effective December 28, 2026, removes 14 of 60 health IT certification criteria, including AI transparency regulations, potentially saving $1.5 billion in regulatory costs. This change affects how hospitals evaluate AI tools, as developers are no longer required to provide source attributions.

What it means

Health systems must establish their own evaluation criteria for AI tools, emphasizing disclosure, validation, and bias testing. Leaders should revise procurement contracts to include these elements by the end of 2026 to maintain safety standards.

8

Monitor hospitals' procurement adjustments and contract updates before the new rule's implementation in late 2026.

Dates to keep

Thursday, November 12, 2026, Healthleap AI Screening Symposium: This event will showcase Healthleap's advancements in AI-driven hospital screenings, following their recent $38M funding to address undiagnosed conditions, as noted in our October 18 edition.

Friday, November 13, 2026, CMS Electronic Prior Authorization Update: CMS will provide an update on the progress of their electronic prior authorization initiative, which has gained support from Amazon and Google, as highlighted in our October 25 edition.

Saturday, November 14, 2026, Anthropic's Model Context Protocol Webinar: Anthropic will host a webinar on their Model Context Protocol (MCP), which could significantly impact MedTech data integration, a development we first discussed in our October 18 edition.